Top Markets
Coin of the day
Medios AG Medios AG

Medios AG

ILM1
Clasificación en acciones #15684
Medios AG, together with its subsidiaries, supplies specialty pharmaceutical... Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. It operates through three segments: Patient-Specific Therapies; International Business; and Pharmaceutical Supply. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies. This segment also includes cytostatic preparations, antibody therapies, and parenteral nutrition solutions. The International Business International covers all activities in the international environment from the procurement of Active Pharmaceutical Ingredients, the sterile and non-sterile drugs and the supply of public and hospital pharmacies through homecare service. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. Medios AG is founded in 2015 and was headquartered in Berlin, Germany.
Precio por acción
$13.21
Capitalización bursátil
$337.03M
Cambio (1 día)
-0.36%
Cambio (1 año)
-28.32%
País
DE
Comercio Medios AG (ILM1)

Categoría

Ganancias de Medios AG (ILM1)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Medios AG, gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Medios AG desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
$6.46B -
US
- -
US
$2.17B -
US
- -
US
$708.86M -
AU